Hypoxia and estrogen are functionally equivalent in breast cancer-endothelial cell interdependence

Molecular Cancer

Volumn 11, Issue , 2012, Pages

  George, Andrea L ^a   Rajoria, Shilpi ^a   Suriano, Robert ^a   Mittleman, Abraham ^a   Tiwari, Raj K ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Breast cancer; Estrogen; Hypoxia; Hypoxia inducible factor; Neovasculogenesis; Vascular endothelial growth factor

Indexed keywords

CYCLOHEXIMIDE; ESTRADIOL; ESTROGEN; FULVESTRANT; HYPOXIA INDUCIBLE FACTOR 1; LIFICIGUAT; PROTEIN KINASE B; VASCULOTROPIN; WORTMANNIN;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL INTERACTION; CELL LINE; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; EPITHELIUM CELL; ESTROGEN BLOOD LEVEL; ESTROGEN RELEASE; GENE TRANSLOCATION; HORMONE ACTION; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ANOXIA; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL NUCLEUS; ENDOTHELIAL CELLS; ESTROGENS; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

MURINAE;

EID: 84867657443     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-11-80     Document Type: Article

References (39)

1. Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol 2001, 2:133-140. 10.1016/S1470-2045(00)00254-0, 11902563.
2. Kelsey JL, Horn-Ross PL. Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev 1993, 15(1):7-16.
3. Kelsey JL, Bernstein L. Epidemiology and prevention of breast cancer. Annu Rev Public Health 1996, 17:47-67. 10.1146/annurev.pu.17.050196.000403, 8724215.
4. Lilienfeld AM. The epidemiology of breast cancer. Cancer Res 1963, 23(9):1503-1513.
5. Habel LA, Stanford JL. Hormone receptors and breast cancer. Epidemiol Rev 1993, 15:209-219.
6. Li CI, Daling JR, Malone KE. Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol 2003, 21(1):28-34. 10.1200/JCO.2003.03.088, 12506166.
7. Castoria G, Migliaccio A, Giovannelli P, Auricchio F. Cell proliferation regulated by estradiol receptor: Therapeutic implications. Steroids 2010, 75:524-527. 10.1016/j.steroids.2009.10.007, 19879889.
8. Björnström L, Sjöberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 2005, 19(4):833-842. 10.1210/me.2004-0486, 15695368.
9. Fox EM, Andrade J, Shupnik MA. Novel action of estrogen to promote proliferation: Integration of cytoplasmic and nuclear pathways. Steroids 2009, 74:622-627. 10.1016/j.steroids.2008.10.014, 2702758, 18996136.
10. Levin ER. Plasma membrane estrogen receptors. Trends Endocrinol Metab 2009, 20(10):477-482. 10.1016/j.tem.2009.06.009, 19783454.
11. Manavathi B, Kumar R. Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin. J Cell Physiol 2006, 207(3):594-604. 10.1002/jcp.20551, 16270355.
12. Sun M, Paciga JE, Feldman RI, Yuan Z, Coppola D, Lu YY, Shelley SA, Nicosia SV, Cheng JQ. Phosphatidylinositol-3-OH kinase (PI3K)/AKT2, activated in breast cancer, regulates and is induced by estrogen receptor α (ERα) via interaction between ERα and PI3K. Cancer Res 2001, 61:5985-5991.
13. Bratton MR, Duong BN, Elliott S, Weldon CB, Beckman BS, McLachlan JA, Burow ME. Regulation of ERalpha-mediated transcription of Bcl-2 by PI3K-AKT crosstalk: implications for breast cancer cell survival. Int J Oncol 2010, 37(3):541-550.
14. Lee YR, Park J, Yu HN, Kim JS, Youn HJ, Jung SH. Up-regulation of PI3K/Akt signaling by 17β-estradiol through activation of estrogen receptor-α, but not estrogen receptor-β, and stimulates cell growth in breast cancer cells. Biochem Biophys Res Commun 2005, 336:1221-1226. 10.1016/j.bbrc.2005.08.256, 16169518.
15. Kimbro KS, Simons JW. Hypoxia-inducible factor-1 in human breast and prostate cancer. Endocr Relat Cancer 2006, 13:739-749. 10.1677/erc.1.00728, 16954428.
16. Weidemann A, Johnson RS. Biology of HIF-1α. Cell Death Differ 2008, 15:621-627. 10.1038/cdd.2008.12, 18259201.
17. Du R, Lu KV, Petritsch C, Liu P, Ganss R, Passegué E, Song H, VandenBerg S, Johnson RS, Werb Z, Bergers G. HIF1α induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 2008, 13:206-220. 10.1016/j.ccr.2008.01.034, 2643426, 18328425.
18. Hoenig MR, Bianchi C, Sellke FW. Hypoxia inducible factor-1α, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: a unifying hypothesis. Curr Drug Targets 2008, 9:422-435. 10.2174/138945008784221215, 18473772.
19. Russo TM, Di Vito M, Sale P, Pellegrini L, Schito L, Gentileschi S, Bracaglia R, Marandino F, Garaci E, Russo MA. Up-regulation of pro-inflammatory genes as adaptation to hypoxia in MCF-7 cells and in human mammary invasive carcinoma microenvironment. Cancer Sci 2010, 101(4):1014-1023. 10.1111/j.1349-7006.2010.01493.x, 20151982.
20. Kazi AA, Koos RD. Estrogen-induced activation of hypoxia-inducible factor-1α, vascular endothelial growth factor expression, and edema in the uterus are mediated by the phosphatidylinositol 3-kinase/Akt pathway. Endocrinology 2007, 148(5):2363-2374. 10.1210/en.2006-1394, 17272396.
21. Kazi AA, Molitoris KH, Koos RD. Estrogen rapidly activates the PI3K/AKT pathway and hypoxia-inducible factor 1 and induces vascular endothelial growth factor A expression in luminal epithelial cells of the rat uterus. Biol Reprod 2009, 81:378-387. 10.1095/biolreprod.109.076117, 2849827, 19420388.
22. Kazi AA, Jones JM, Koos RD. Chromatin immunoprecipitation analysis of gene expression in the rat uterus in vivo: estrogen-induced recruitment of both estrogen receptor alpha and hypoxia-inducible factor 1 to the vascular endothelial growth factor promoter. J Mol Endocrinol 2005, 19:2006-2019.
23. Hua K, Din J, Cao Q, Feng W, Zhang Y, Yao L, Huang Y, Zhao Y, Feng Y. Estrogen and progestin regulate HIF-1α expression in ovarian cancer cell lines via the activation of Akt signaling transduction pathway. Oncol Rep 2009, 21:893-898.
24. Gao N, Nester RA, Sarkar MA. 4-hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells. Toxicol Appl Pharmacol 2004, 196:124-135. 10.1016/j.taap.2003.12.002, 15050414.
25. Zhong H, De Marzo AM, Laughner E, Lim M, Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL, Simons JW. Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastasis. Cancer Res 1999, 59:5830-5835.
26. Bos R, Zhong H, Hanrahan CF, Mommers EC, Semenza GL, Pinedo HM, Abeloff MD, Simons JW, van Diest PJ, van der Wall E. Levels of hypoxia-inducible factor-1α during breast carcinogenesis. J Natl Cancer Inst 2001, 93(4):309-314. 10.1093/jnci/93.4.309, 11181778.
27. Gupta PB, Kuperwasser C. Contributions of estrogen to ER-negative breast tumor growth. J Steroid Biochem Mol Biol 2006, 102:71-78. 10.1016/j.jsbmb.2006.09.025, 17049443.
28. Bendrik C, Dabrosin C. Estradiol increases IL-8 secretion of normal human breast tissue and breast cancer in vivo. J Immunol 2009, 182(1):371-378.
29. Nilsson UW, Abrahamsson A, Dabrosin C. Angiogenin regulation by estradiol in breast tissue: tamoxifen inhibits angiogenin nuclear translocation and antiangiogenin therapy reduces breast cancer growth In vivo. Clin Cancer Res 2010, 16(14):3659-3669. 10.1158/1078-0432.CCR-10-0501, 20501617.
30. Suriano R, Chaudhuri D, Johnson RS, Lambers E, Ashok BT, Kishore R, Tiwari RK. 17β-estradiol mobilizes bone marrow-derived endothelial progenitor cells to tumors. Cancer Res 2008, 68:6038-6042. 10.1158/0008-5472.CAN-08-1009, 18676823.
31. George AL, Bangalore-Prakash P, Rajoria S, Suriano R, Shanmugam A, Mittelman A, Tiwari RK. Endothelial progenitor cell biology in disease and tissue regeneration. J Hematol Oncol 2011, 4:24-32. 10.1186/1756-8722-4-24, 3123653, 21609465.
32. He Q, Gao Z, Yin J, Zhang J, Yun Z, Ye J. Regulation of HIF-1α activity in adipose tissue by obesity-associated factors: adipogenesis, insulin, and hypoxia. Am J Physiol Endocrinol Metab 2011, 300(5):877-885.
33. Mabjeesh NJ, Willard MT, Frederickson CE, Zhong H, Simons JW. Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phoshatidylinositol 3-kinase/protein kinase B in prostate cancer cells. Clin Cancer Res 2003, 9(7):2416-2425.
34. Voss MJ, Möller MF, Powe DG, Niggemann B, Zänker KS, Entschladen F. Luminal and basal-like breast cancer cells show increased migration induced by hypoxia, mediated by an autocrine mechanism. BMC Cancer 2011, 11:158-170. 10.1186/1471-2407-11-158, 3114792, 21535870.
35. Fujiwara S, Nakagawa K, Harada H, Nagato S, Furukawa K, Teraoka M, Seno T, Oka K, Iwata S, Ohnishi T. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas. Int J Oncol 2007, 30(4):793-802.
36. Soeda A, Park M, Lee D, Mintz A, Androutsellis-Theotokis A, McKay RD, Engh J, Iwama T, Kunisada T, Kassam AB, Pollack IF, Park DM. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α. Oncogene 2009, 28:3949-3959. 10.1038/onc.2009.252, 19718046.
37. Meininger CJ, Schelling ME, Granger HJ. Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. Am J Physiol 1988, 255:554-562.
38. Shweiki D, Ahuva I, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359:843-845. 10.1038/359843a0, 1279431.
39. Brown LF, Berse B, Jackman RW, Tognazzi K, Guidi AJ, Dvorak HF, Senger DR, Connolly JL, Schnitt SJ. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 1995, 26(1):86-91. 10.1016/0046-8177(95)90119-1, 7821921.